HSN-1B

2003

What Is HSN-1B?

HSN-1B is a type of CMT with an established locus but no confirmed causative gene identified to date.

For HSN-1B, genetic evidence supports an autosomal dominant inheritance pattern, meaning that just one of the gene’s two copies needs a mutation to cause this subtype.

Clinical Features

The age of symptom onset in HSN-1B is variable, ranging from childhood to adulthood. Symptoms typically begin in the lower extremities and progress over time to involve the upper limbs. Nerve conduction studies usually show somewhat slowed conduction velocities and reduced amplitudes, consistent with an axonal form of CMT.

HSN-1B symptoms may include:

  • Weakness in the feet and lower legs
  • Muscle atrophy
  • Foot drop
  • Reduced or absent reflexes
  • Reduced sensation
  • A steppage-style walking pattern
  • Foot deformities, including high arches, and hammertoes (clawed toes)
  • Progressive involvement of the hands and forearms
  • Difficulty with fine motor skills and manual dexterity
  • Additional symptoms not listed here

Disease Course

HSN-1B shows wide variability in severity and progression. Some individuals are mildly affected, while others develop a more severe disease. Disease progression is generally slow, and life expectancy is not reduced.

Clinical Basics

Subtype
HSN-1B

Classification
HSN

Neuropathy Type
Axonal

Inheritance Pattern
autosomal dominant

Genetic Context

HGNC-Approved Gene Symbol
Gene is Unknown at This Time

Chromosome
3p22-p24

Zygosity of Responsible Variant
Heterozygous

Variant Mechanism

Unknown

Details

Mechanistic basis:
Gene unknown

Confidence:
High

Prediction:
Linkage in a dominantly transmitted sensory neuropathy kindred places HSN-1B in an interval at 3p22-p24, and the clinical picture combines adult-onset sensory loss with chronic cough and gastroesophageal reflux. No gene within the interval has been cloned and no segregating allele has been characterized, so the literature identifies a map position rather than a protein and supports no molecular mechanism.

Rationale:
A mechanism requires an allele acting on a product, and HSN-1B has neither on record: the interval holds multiple transcripts and none confirmed to track with the phenotype. Dominant transmission does constrain what the eventual gene could be doing, since one altered copy suffices, but a mode of inheritance is not a mechanism.

HSN-1B OMIM Entry

HSN-1B OMIM

More Info

HSN-1B Research Opportunity

CMT Natural History Study

Original Discovery Publication

Publication Title

Locus for Hereditary Sensory Neuropathy with Cough and Gastroesophageal Reflux on Chromosome 3p22-p24

Authors

Kok, C., Kennerson, M. L., Spring, P. J., Ing, A. J., Pollard, J. D., & Nicholson, G. A

Publication Date
September 1, 2003

Updated: July 18, 2026 | By: K. Raymond

The Dorsal Root

More From The Dorsal Root


A Name That Does Too Much Work

Jean-Martin Charcot's name appears throughout medicine, but nowhere does it create more confusion than in the foot. Learn why the CMT foot and Charcot neuroarthropathy, also known as Charcot foot, share a name yet differ in how they develop, appear, and are managed.


When Medicine Lost Its Compass

Evidence failed not because it was wrong, but because it was weaponized. I lived the downstream effects of that failure for more than a decade. This is what happens when medicine forgets that data always ends in a human being.


Error 404: Gene Not Found

CMT genetic testing often fails to identify the cause of the disease, even when comprehensive panels are used. Here, we discuss why this happens, what genetic tests can and cannot do, and why a negative result still matters.